Investigation of mutant frequency at the HPRT locus and changes in microsatellite sequences in healthy young adults

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 431, Issue 2, 1999, Pages 317-323

  Davies, Margaret J ^a   Turner, Joanne G ^a   Vives Bauza, Cristofol ^a   Rumsby, Paul C ^a  

^a BIBRA Intl Woodmansterne Rd C ^*  (United Kingdom)

Author keywords

Genetic polymorphisms; Human HPRT; Microsatellites

Indexed keywords

ADULT; ARTICLE; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MUTATION RATE; NORMAL HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ARYLAMINE N-ACETYLTRANSFERASE; CYTOCHROME P-450 CYP1A1; FEMALE; GLUTATHIONE TRANSFERASE; GREAT BRITAIN; HETEROZYGOTE; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MALE; MICROSATELLITE REPEATS; MUTATION; NEUROFIBROMIN 1; POLYMORPHISM, GENETIC; PROTEINS; SEQUENCE DELETION; T-LYMPHOCYTES; VARIATION (GENETICS);

EID: 0033397743     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00175-X     Document Type: Article

References (22)

1. Tates A.D., van Dam F.J., van Mossel H., Schoemaker H., Thijssen J.P.C., Woldring V.M., Zwinderman A.H., Natarajan A.T. Use of the clonal assay for the measurement of frequencies of HPRT mutants in T-lymphocytes from five control populations. Mutat. Res. 253:1991;199-213.
2. Branda R.F., Sullivan L.M., O'Neill J.P., Falta M.T., Nicklas J.A., Hirsch B., Vacek P.M., Albertini R.J. Measurement of HPRT mutant frequencies in T-lymphocytes from healthy human populations. Mutat. Res. 285:1993;267-279.
3. Cole J., Skopek T.R. Somatic mutant frequency, mutation rates and mutational spectra in the human population in vivo. Mutat. Res. 304:1994;33-105.
4. Hou S.-M., Lambert B., Hemminki K. Relationship between HPRT mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis. 16:1995;1913-1917.
5. Scarpato R., Migliore L., Hirvonen A., Falck G., Norppa H. Cytogenetic monitoring of occupational exposure to pesticides: characterisation of GSTM1, GSTT1 and NAT2 genotypes. Environ. Molec. Mutagen. 27:1996;263-269.
6. Kawajiri K., Nakachi K., Imai K., Yoshii A., Shinoda N., Watanabe J. Identification of genetically high risk individuals to lung cancer by polymorphisms of the cytochrome P4501A1 gene. FEBS Lett. 263:1990;131-133.
7. Skog K. Cooking procedures and food mutagens: a literature review. Food Chem. Toxicol. 31:1993;655-675.
8. Puga A., Nebert D.W., McKinnon R.A., Menon A.G. Genetic polymorphisms in human drug-metabolising enzymes: potential uses of reverse genetics to identify genes of toxicological relevance. Crit. Rev. Toxicol. 27:1997;199-222.
9. Verhagen H., van Poppel G. Short-term consumption of brussels sprouts leads to an increase in detoxifying glutathione-S-transferase enzymes and to a decrease in oxidative DNA-damage in human volunteers. Sadler M.J., Saltmarsh M. Functional Foods - The Consumer, the Products and the Evidence. Publ. R. Soc. Med. 1998;106-110.
10. Perera F.P. Molecular epidemiology: insights into cancer susceptibility, risk assessment and prevention. J. Natl. Cancer Inst. 88:1996;496-509.
11. Holzman D. Mismatch repair genes matched to several new roles in cancer. J. Natl. Cancer Inst. 88:1996;950-951.
12. Glabb W.E., Tindall K.R. Mutation rate at the HPRT locus in human cancer cell lines with specific mismatch repair-gene defects. Carcinogenesis. 18:1997;1-8.
13. Davies M.J., Lovell D.P., Anderson D. Thioguanine-resistance mutant frequency in T-lymphocytes from a healthy human population. Mutat. Res. 265:1992;165-171.
14. Bell D.A., Taylor J.A., Paulson D.F., Robertson C.N., Mohler J.L., Lucier G.W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl. Cancer Inst. 85:1993;1159-1164.
15. Hayashi S.-I., Watanabe J., Nakacki N., Kawajiri K. Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P4501A1 gene. J. Biochem. 110:1991;407-411.
16. Sivaraman L., Leatham M.P., Yee J., Wilkins L.R., Lau A.F., Le Marchand L. CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res. 54:1994;3692-3695.
17. Cole J., Green M.H.L., James S.E., Henderson L., Cole H. A further assessment of factors influencing measurements of thioguanine-resistant mutant frequency in circulating T-lymphocytes. Mutat. Res. 204:1988;493-507.
18. Hou S.-M., Fält S., Steen A.-M. HPRT mutant frequency and GSTM1 genotype in non-smoking healthy individuals. Environ. Mol. Mutagen. 25:1995;97-105.
19. Hackman P., Gabbani G., Österholm A.-M., Hellgren D., Lambert B. Spontaneous length variation in microsatellite DNA from human T-cell clones. Genes, Chromosomes Cancer. 14:1995;1-5.
20. Satoh C., Takahashi N., Asakawa J.-I., Kodaira M., Kuick R., Hanash S.M., Neel J.V. Genetic analysis of children of atom bomb survivors. Environ. Health Perspect. 104:1996;511-519.
21. Li C.-Y., Yandell D.W., Little J.B. Elevated frequency of microsatellite mutations in TK6 human lymphocyte clones selected for mutations at the thymidine kinase locus. Molec. Cell. Biol. 14:1994;4373-4379.
22. Bhattacharyya N., Skandalis A., Ganesh A., Groden J., Meuth M. Mutator phenotypes in colorectal carcinoma cell lines. Proc. Natl. Acad. Sci. USA. 91:1994;6319-6323.